DEA Sends Telehealth Extension Regulation to OMB for Review-The Drug Enforcement Administration (DEA) is expected to officially extend COVID-era flexibilities related to the prescribing of controlled substances via telemedicine. The agency recently sent a final rule titled “Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Substances” to the Office of Management and …
Continue reading “DEA Sends Telehealth Extension Regulation to OMB for Review”
Listen and subscribe to this week’s episode of the Health on the Hill Podcast: Apple Podcasts Spotify YouTube SoundCloud
Policymakers Spotlight GLP-1 Counterfeits, Costs-A bipartisan group of House Energy and Commerce Committee members have sent a letter to the Food and Drug Administration (FDA) requesting a briefing from the agency about the presence of counterfeit Ozempic and other similar products in the nation’s medical supply chain. The lawmakers express concerns about potential gaps in …
Continue reading “Policymakers Spotlight GLP-1 Counterfeits, Costs”
Listen and subscribe to this week’s episode of the Health on the Hill Podcast: Apple Podcasts Spotify YouTube SoundCloud
Senators Maintain Spotlight on Steward Healthcare-A group of Massachusetts Democrats have sent a letter to the CEO of Rural Healthcare Group regarding the company’s acquisition of Steward Health Care’s physician group Stewardship Health. “We are concerned about the risks to Massachusetts residents and health professionals, who are still suffering from the private equity-induced damage of …
Continue reading “Senators Maintain Spotlight on Steward Healthcare”